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Background/Purpose: Abdominal nontuberculous mycobacterial infection is a rare condition. Continuous
ambulatory peritoneal dialysis (CAPD)-associated peritonitis is the most common manifestation of infection
due to nontuberculous mycobacteria (NTM). There are limited data on the clinical manifestations of
nontuberculous mycobacterial infection. This study investigated the diagnostic features, clinical presentation,
mycobacteriology, treatment and outcome of all abdominal NTM infections treated over a 7-year period at a
major teaching hospital in Taiwan.
Methods: The medical records of all patients with a diagnosis of abdominal NTM infection from January
1997 through to December 2003 were retrospectively reviewed.
Results: All 11 patients with abdominal NTM infections identified during the 7-year period were included.
Among these patients, six were male and five were female, with a mean age of 64.5 years. The disease manifested
as peritonitis (9 patients, 82%), splenic abscess (1, 9%), or perirenal abscess (1, 9%). Most patients (73%)
had underlying malignancy, most often hepatoma (45%). Immunocompromised status (liver cirrhosis,
malignancy, acquired immunodeficiency syndrome) was noted in 10 patients (91%). None of our patients
who developed NTM peritonitis had received CAPD. The peritoneal fluid appearance varied considerably,
with no particular predominance of clear, turbid, bloody, or chylous findings. Rapidly growing mycobacteria
were the major etiology (46%) of abdominal NTM infection, and Mycobacterium abscessus played a major role
(27%). Overall, eight patients died, and only one patient survived longer than 1 year. Seven patients (64%)
died before diagnosis.
Conclusion: Abdominal NTM infection is frequently overlooked because of its rarity and nonspecific
symptoms, with consequent delays in diagnosis and treatment. In immunocompromised patients with ascites
from any cause (liver cirrhosis, malignant ascites, etc.), NTM peritonitis should be considered early in the
differential diagnosis of symptoms including fever, abdominal pain and weight loss. The poor prognosis of
abdominal NTM infection appears to be related to the severity of underlying conditions, most often
malignancy. [J Formos Med Assoc 2006;105(5):370–376]
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More than 50 species of the genus Mycobacterium
are now recognized as potential human patho-
gens. Species other than Mycobacterium tuberculosis
and Mycobacterium leprae have been designated
“atypical mycobacteria” or “mycobacteria other
than Mycobacterium tuberculosis” in the past, but are
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now simply called “nontuberculous myco-
bacteria” (NTM). NTM are ubiquitous in the envi-
ronment and are readily isolated from water, soil,
domestic and wild animals, milk, and foods.1–3 A
wide variety of diseases are caused by NTM, in-
cluding disseminated infection predominantly in
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mens for cultures of mycobacteria followed the rec-
ommended guidelines.10 Cultures for myco-
bacteria were performed by inoculating the speci-
men onto Middlebrook 7H11 selective agar with
antimicrobials (BBL, Becton Dickinson, Sparks,
MD, USA) and by the fluorometric BACTEC tech-
nique (BACTEC MGIT 960 system; Becton-Dickin-
son Diagnostic Instrument Systems, Sparks, MD,
USA) as previously described. NTM were identi-
fied to the species level using conventional bio-
chemical methods.10
Definition of abdominal NTM infection
Abdominal infection due to NTM was diagnosed
based on the positive culture of NTM from an ab-
dominal source. Only patients with abdominal
NTM infections meeting this diagnostic criterion
were included in the study.
Patient characteristics
Data on patient characteristics were collected and
analyzed, including age at the first visit, gender,
time from onset of symptoms to diagnosis, symp-
toms and signs, site of involvement, findings on
chest radiography and other imaging modalities
used, microbiologic findings, histologic and patho-
logic findings, underlying medical condition, di-
agnostic investigations, treatment and outcome.
Treatment
Treatment was considered to be appropriate if the
regimen followed the guidelines of the American
Thoracic Society:4 (1) clarithromycin or azithromy-
cin plus ethambutol based regimen for Mycobacte-
rium avium complex (MAC) disease; (2) isoniazid,
rifampin and ethambutol based regimen for Myco-
bacterium kansasii disease; (3) regimen for rapidly
growing mycobacteria should include drugs such
as amikacin and clarithromycin, based on in vitro
susceptibility tests.
Results
Demographic characteristics
Abdominal NTM infection was diagnosed in 11
patients with acquired immunodeficiency syn-
drome (AIDS), skin and soft-tissue infection, pul-
monary infections, lymphadenitis, keratitis, and
abdominal infections including peritonitis.4 NTM
have been implicated in an increasing number of
infections throughout the world.
Abdominal mycobacterial infections were pre-
dominantly described as tuberculous infections.
Abdominal tuberculosis (TB), which may involve
the gastrointestinal tract, peritoneum, lymph nodes
or solid viscera, constitutes up to 12% of extra-
pulmonary TB and 1–3% of the total.5,6 The dis-
ease can mimic many conditions, including in-
flammatory bowel disease, malignancy and other
infectious diseases. Mycobacterial infections are
an uncommon but well-recognized cause of con-
tinuous ambulatory peritoneal dialysis (CAPD)-
associated peritonitis, and the vast majority of
these infections are due to TB.7
Abdominal infections caused by NTM are rare-
ly mentioned in the literature. Among these
infections, peritonitis caused by NTM has a parti-
cularly high mortality rate. The first two cases of
NTM CAPD peritonitis were reported in 1983 by
Pulliam et al and were both fatal.8 A review of re-
ported cases of NTM CAPD peritonitis up to 1993
revealed that the majority were due to rapidly
growing mycobacteria, especially Mycobacterium
fortuitum.9 Abdominal infections caused by NTM
may present as peritonitis, lymphadenitis, and
abscess formation. There are limited data on the
natural history and optimal antimicrobial therapy
of abdominal NTM infection, both of which are
continually evolving. This study analyzed the clin-
ical characteristics and mycobacteriology of ab-
dominal NTM infection in a university hospital in
Taiwan from 1997 to 2003.
Methods
NTM isolates
We retrospectively reviewed the records from the
Mycobacteriology Laboratory of National Taiwan
University Hospital from January 1997 to Decem-
ber 2004. Preparation of different clinical speci-
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patients from January 1997 to December 2003,
with no cases diagnosed in 1998. These 11 pa-
tients included six men and five women, with a
mean age of 64 ± 8 years (range, 52–80 years). The
most common underlying condition was malig-
nancy, especially hepatoma, followed by liver
cirrhosis (Table 1). Only one patient had AIDS.
One patient had active TB pyomyositis, and two
patients had previously been treated for pulmo-
nary TB.
Site of involvement
Peritoneal involvement (9 patients, 82%) was the
most common manifestation of the disease. One
patient (9%) presented with perirenal abscess and
one (9%) with splenic abscess.
Clinical characteristics
The most common symptom was fever (8 patients,
73%), and abdominal distension was the most
common sign (9 patients, 82%), followed by ab-
dominal tenderness and jaundice (Table 1). The
nature of the pain was usually diffuse. Nine pa-
tients had ascites with evidence of NTM peritoni-
tis. One patient with perirenal abscess presented
with palpable abdominal mass and flank pain. One
patient with relapsing polychondritis presented
with progressive dyspnea and fever for 10 days, and
splenic abscess was found on abdominal com-
puted tomography (CT). The average duration from
onset of symptoms to diagnosis was 2 months,
despite the short duration of less than 2 weeks
from symptom onset to seeking medical help in
half of the patients. Concurrent bacteremia or fun-
gemia developed in four patients. A 69-year-old
man with diabetes mellitus, liver cirrhosis and der-
matomyositis developed MAC peritonitis and con-
current tuberculous and Acinetobacter baumannii
pyomyositis and Candida glabrata fungemia. De-
spite receiving extensive medical attention, he died
before NTM peritonitis was diagnosed. A 60-year-
old woman with breast cancer and multiple me-
tastasis developed M. chelonae peritonitis and
concurrent multiflora bacteremia (Pseudomonas
aeruginosa, Enterobacter cloacae, Acinetobacter
baumannii).
Laboratory evaluation
White blood cell (WBC) counts were elevated
(range, 11,890–24,650/mm3) in six patients. The
average leukocyte count in all patients was 12,520/
mm3 (range, 5140–24,650/mm3). All patients had
anemia, and 72.7% had abnormal liver function
(Table 1). Nine patients developed ascites, with
turbid, bloody or chylous appearance. Only six
patients had exudative ascites (Table 1). Elevated
C-reactive protein was noted in all patients, with
Table 1. Underlying conditions, clinical manifestations and
laboratory findings of 11 patients with abdominal
nontuberculous mycobacterial infection
Clinical features n (%)
Underlying condition
Malignancy* 8 (73)
Liver cirrhosis 6 (55)
Old or active tuberculosis infection 3 (27)
Diabetes mellitus 3 (27)
Acquired immunodeficiency syndrome 1 (9)0
Symptoms and signs
Fever 8 (73)
Abdominal pain 5 (46)
Weight loss 4 (36)
Anorexia 3 (27)
Abdominal distension or ascites 9 (82)
Jaundice 6 (55)
Abdominal tenderness 5 (46)
Laboratory findings
Serum 11
Anemia† 11 (100)
Aspartate aminotransferase > 40/mm3 8 (73)
Platelet count < 150,000/mm3 7 (64)
White blood cell count > 11,000/mm3 6 (55)
Total bilirubin > 2.0 μg/dL 5 (46)
Albumin < 3.0 g/dL 5 (46)
Ascitic fluid 9
Appearance
Turbid 3 (33)
Clear 2 (22)
Bloody 2 (22)
Chylous 2 (22)
Exudative 6 (67)
White blood cell count * 500/mm3 4 (44)
*Four patients had hematoma: one patient had hepatoma and nasopharyngeal
carcinoma, one patient had breast cancer, and one patient had ovarian mucinous
cystadenocarcinoma; †hematocrit < 40% in men and hematocrit < 33% in women.
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a mean value of 7.46 mg/dL (2.02–18 mg/dL). As-
cites leukocyte count ranged from 100 to 4500/
mm3.
Mycobacteriology
Acid-fast bacilli (AFB) smear was positive in only
one of 11 patients with positive nontuberculous
mycobacterial cultures. Rapidly growing myco-
bacteria were the major (46%) etiology of abdom-
inal NTM infection, and Mycobacterium abscessus
played a major role (27%) (Table 2). Only two
patients had abdominal NTM infection caused by
MAC (18%).
Radiographic findings
Chest radiographs obtained at admission were
negative for lung lesions in six patients, and
showed various lung lesions in five patients, in-
cluding consolidation, right upper lobe collapse
and linear atelectasis. None of the patients had a
diagnosis of pulmonary TB. Abdominal CT was
performed in 10 patients, and revealed ascites (9
patients), hepatic tumor (6 patients) and paraaor-
tic lymph node enlargement (4 patients) as the
most common findings.
Treatment and outcome
Abdominal NTM infection was diagnosed with-
in 3 months of symptom presentation in all pa-
tients, but was diagnosed within 1 month in only
two patients; the mean diagnostic delay was 2.2
months. Most patients died before NTM peri-
tonitis was diagnosed (Table 3). Ascites culture
yielded NTM in nine patients. Only two patients
received medical treatment for NTM peritonitis.
One of them died during treatment, and the other,
who had M. abscessus splenic abscess, died 5
months after starting treatment. A 62-year-old
woman without obvious underlying disease de-
veloped M. abscessus perirenal abscess 3 months
after extracorporeal shock wave lithotripsy for
renal stones. She was cured after incision and
drainage. In the eight patients who died, four
(50%) had developed concurrent bacteremia or
fungemia, and seven (88%) had malignancy. Three
patients died as a direct result of hepatocellular
carcinoma with tumor rupture. The overall mor-
tality rate was 73%, and the 1-year survival rate
was only 9%.
Discussion
Abdominal nontuberculous mycobacterial in-
fection is rare in the disease spectrum of NTM
infections. In a review of the literature, Rosengart
and Coppa reported that among 21 patients with
abdominal mycobacterial infections in 1990,
Table 2. Mycobacterial species in 11 patients
with abdominal nontuberculous
mycobacterial infection
Mycobacterial species n (%)
Rapidly growing mycobacteria 5 (46)
Mycobacterium abscessus 3 (27)
Mycobacterium fortuitum 1 (9)0
Mycobacterium chelonae 1 (9)0
Mycobacterium avium complex 2 (18)
Mycobacterium kansasii 1 (9)0
Mycobacterium gordonae 1 (9)0
Mycobacterial species (nonchromogen) 2 (18)
Table 3. Treatment and outcome of 11
patients with abdominal
nontuberculous mycobacterial
infection
n (%)
Duration of symptoms before diagnosis
1 to < 3 mo 9 (82)
< 1 mo 2 (18).
Died before diagnosis 7 (64)
Treatment
Inappropriate treatment 9 (82)
Appropriate medical treatment 0.2 (18)*
Incision and drainage 1 (9)0
Mortality 8 (73)
*One patient with Mycobacterium avium complex infection was
treated with ciprofloxacin, clarithromycin and ethambutol for 2
weeks until the patient died, while the other patient with
Mycobacterium abscessus peritonitis was treated with
clarithromycin and amikacin for 4 months until the patient died.
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four had MAC isolated, and two of these patients
had AIDS.11 They found no difference in the pre-
sentation or clinical course of patients with in-
fection due to TB or NTM.11 NTM infections are a
rare but important cause of infections in CAPD
patients.8,9,12,13 The incidence of mycobacterial peri-
tonitis in CAPD patients has been reported to be
< 3%.7 M. fortuitum was the most common NTM
catheter-related infection in CAPD patients, and
these patients are at increased risk of NTM infec-
tion because of the risk factors of immunocom-
promise and invasive catheterization.13
The present study analyzed the characteristics
of all 11 patients with abdominal NTM infections
from 1997 to 2003 in a major teaching hospital
in Taiwan. The NTM infections in these patients
included peritonitis, splenic abscess and peri-
renal abscess. Peritonitis of NTM etiology has only
been previously reported in CAPD patients, but
none of our patients were on CAPD. Only one of
the 11 patients in this series was immunocom-
petent. Immunocompromised conditions were
characterized by evidence of concurrent bacteremia,
malignancy or liver cirrhosis; only one patient had
AIDS (Table 1). The mean age of the patients in
this series of abdominal NTM infection (64 ± 8
years) is older than in prior reports of abdominal
mycobacterial infection (36 ± 8 years)11 and ab-
dominal TB (40 ± 14 years).14 Infection with M.
tuberculosis has been reported as a sentinel in pa-
tients with AIDS or other immunocompromised
conditions, whereas NTM infections usually oc-
cur later in the course of immunodeficient dis-
orders.11 The immunodeficient disorders in our
study were obvious, with malignancy being the
main risk factor. Among the eight patients with
malignancy, three had distant metastasis, and
one patient had double cancer with hepatocellu-
lar carcinoma and nasopharyngeal carcinoma.
Hepatoma, metastatic hepatic tumor, and malig-
nant ascites accounted for 63.6% of the patients.
Concurrent bacteremia or fungemia were noted
in four patients, reflecting their underlying immu-
nocompromised status. Diseases associated with
the development of ascites in this study included
liver cirrhosis and malignancy. The ascites cultures
in these seven patients yielded NTM. The interac-
tion between ascites produced by underlying dis-
eases and NTM peritonitis remains unclear. Previ-
ous reports of NTM peritonitis were all CAPD-
related peritonitis, but none of our patients who
developed this condition had received CAPD.
The most common clinical presentations of ab-
dominal TB in previous reports were a triad of ab-
dominal pain, fever and weight loss.14–16 The same
triad of symptoms was also the most common
physical signs in this series. However, although
previous studies found that the most common
physical signs were fever, ascites and abdominal
mass,14–16 in this series, we found that ascites, ab-
dominal tenderness and jaundice were the most
common signs. This discrepancy is probably attrib-
utable to the greater number of patients with liver
cirrhosis and hepatic tumor in this study. How-
ever, in considering these differences, it should also
be noted that clinical symptoms and physical find-
ings are nonspecific in many patients with NTM
peritonitis.
Abdominal TB has been reported to be associ-
ated with the laboratory findings of mild anemia,
normal or increased leukocyte count, and transam-
inase abnormalities.16 All of the patients in our se-
ries had anemia; five patients had normal leukocyte
count and six had increased leukocyte count.
Transaminase abnormalities were noted in 73%
of patients. A decreased platelet count was also
noted in 64% of patients in this study. Decreased
serum albumin was common in our patients
(55%), which likely represented a combination of
factors including poor nutrition, liver dysfunction
(liver cirrhosis or hepatic tumor), or lymphatic
obstruction.
In the United States, up to 50% of patients with
peritoneal TB may have underlying alcoholic cir-
rhosis, making the diagnosis more difficult.17 The
development of ascites is often attributed solely
to portal hypertension,17,18 and analysis of ascites
often gives mixed results, with both transudate and
exudate features.17,19 In our patients, ascites appear-
ance varied widely from clear to turbid, bloody and
chylous. Bloody ascites was found in two patients
with hepatoma and internal bleeding. Chylous
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ascites was found in two patients, one of whom
had ovarian cystadenocarcinoma with malignant
ascites and the other had hepatocellular carcino-
ma. Transudative ascites was noted in only three
patients, and all of them had evidence of liver cir-
rhosis with portal hypertension. A previous study
suggested that smear of the peritoneal fluid for
AFB is rarely positive in peritoneal TB.19 All nine
patients with ascites in this series had negative
AFB smears and positive cultures for NTM. Periph-
eral leukocytosis was not found in five patients
(leukocyte count ranged from 5140 to 8,430/mm3).
Four of these patients had liver cirrhosis and de-
creased leukocyte count (leukocyte count < 4000/
mm3) during the period prior to infection devel-
opment. The normal leukocyte count in these
patients, however, might still have been elevated
with respect to baseline. A similar number of pa-
tients had predominance of lymphocytes or neu-
trophils in peritoneal fluid leukocytes. Neither
the peritoneal fluid total WBC count nor the dif-
ferential WBC count is helpful to exclude or in-
clude mycobacterial infections in the differential
diagnosis.13
Reported abnormalities on CT in peritoneal TB
include ascites, adenopathy, and omental and
mesenteric thickening. The CT findings in our pa-
tients included ascites, hepatic tumors, splenic
abscess, and perirenal abscess. Paraaortic lymph
node enlargement was noted in four patients; it
might be a sign of previous NTM infection in an
immunocompromised patient with peritonitis or
ascites caused by the development of other con-
ditions or associated with illness progression.
The route of infection in NTM CAPD peritonitis is
likely to be through contamination of the perito-
neal dialysis catheter lumen or the exit site. No
such route of infection was noted in this series.
There might be another route of infection for ab-
dominal NTM infections.
Rapidly growing mycobacteria, especially M.
abscessus, was common (46%) in abdominal NTM
infections in this study. Rapidly growing myco-
bacteria, especially M. fortuitum, was also the most
common pathogen in NTM CAPD peritonitis in
two previous studies.7,13
This study found a high mortality rate and low
1-year survival rate in abdominal NTM infections.
We hypothesize that the virulence of NTM and
the severe underlying conditions and immunocom-
promised status of the patients in this series might
be the main causative factors of the high mortality
rate. The duration from symptom onset to diag-
nosis was 1–3 months in 88% of patients. Death
occurred before diagnosis of abdominal NTM
infection in the majority of patients (7 patients,
64%). Thus, abdominal NTM infection was char-
acterized by delayed or missed diagnosis and
lack of appropriate treatment. Only two patients
received adequate medical treatment, and both of
them died within 1 year of symptom onset. Only
one patient with M. abscessus perirenal abscess was
cured after incision and drainage. She did not re-
ceive adequate medical treatment for M. abscessus,
and her survival might be attributed to a lack of
any underlying disease.
In summary, abdominal NTM infection is fre-
quently overlooked, with consequent delayed di-
agnosis and treatment. In immunocompromised
patients with ascites from any cause (liver cirrhosis,
malignant ascites), NTM peritonitis should be con-
sidered early in the differential diagnosis of symp-
toms like fever, abdominal pain and weight loss.
The poor prognosis in patients with abdominal
NTM infection was related to the severity of the
underlying conditions in this study. NTM CAPD
peritonitis may mainly result from direct inocula-
tion of contaminated water through the peritoneal
catheter. The infection route of abdominal NTM
infection (including NTM peritonitis) in patients
without CAPD may result from other routes of
infection, such as reactivation of a latent myco-
bacterial focus.
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